Predictive Value of Serum Autotaxin for Hepatocellular Carcinoma Recurrence After Curative Radiofrequency Ablation
Serum ATX is a promising biomarker for predicting HCC recurrence post-RFA treatment that may outperform conventional markers.
Authors
- Shun‐ichi Wakabayashi (ORCID: https://orcid.org/0000-0002-4657-4785)
- Takanobu Iwadare (ORCID: https://orcid.org/0000-0003-0430-6819)
- Yūki Yamashita (ORCID: https://orcid.org/0000-0002-0162-4208)
- Taiki Okumura (ORCID: https://orcid.org/0000-0001-5715-1748)
- T. Nakajima
- Hideo Kunimoto
- Naoyuki Fujimori
- Takefumi Kimura (ORCID: https://orcid.org/0000-0002-1481-1029)
- Hiroyuki Kobayashi (ORCID: https://orcid.org/0000-0002-6313-5549)
- Satoshi Shimamoto
- Takuro Uchida
- Koji Igarashi
- Takeji Umemura
- Naoki Tanaka
Institutions
- Shinshu University (JP)
- Oita University (JP)
- Nagano Municipal Hospital (JP)
- Shinshu University Hospital (JP)
- Shinshu Medical and Welfare College (JP)
- Tosoh (Japan) (JP)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1002/cam4.71506
- Primary Topic
- Sphingolipid Metabolism and Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science